Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: A cross-sectional study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hand eczema and temporal variation of Staphylococcus aureus clonal complexes: A prospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The risk of COVID-19 in patients with psoriasis: A retrospective cohort study

    Research output: Contribution to journalLetterpeer-review

  3. The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study

    Research output: Contribution to journalLetterpeer-review

  1. A comparison between self-reported hand eczema and self-reported signs and symptoms of skin lesions indicating hand eczema

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Four emerging immune cellular blood phenotypes associated with disease duration and activity established in Psoriatic Arthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Patients with psoriasis have an impaired quality of life and higher use of analgesics than the general population. Whether such use is due to skin pain or a consequence of joint pain resulting from psoriatic arthritis (PsA) is not clear.

OBJECTIVES: To assess symptoms, disease burden, and use of analgesics in patients with psoriasis with and without PsA.

METHOD: Symptoms, general health (EurQol 5-dimension and 5-levels), and use of analgesics were assessed in patients with psoriasis and the general population from the Danish Skin Cohort.

RESULTS: We included 4016 patients with psoriasis (847 with concomitant PsA) and 3490 reference individuals. For patients with psoriasis having PsA, itch, skin pain, and/or joint pain was associated with worse general health. Use of opioids within 12 months was observed among 9.0% of the general population, 14.2% of patients with psoriasis without PsA, and 22.7% of patients with concomitant PsA. Of the symptoms, only joint pain was associated with use of analgesics (odds ratio, 3.72 (2.69-5.14); P < .0001).

LIMITATIONS: Cross-sectional design.

CONCLUSION: Patients with psoriasis (especially concomitant PsA) have a higher use of analgesics compared with the general population, which appears to be a result of increased joint pain.

Original languageEnglish
JournalJournal of the American Academy of Dermatology
Volume86
Issue number3
Pages (from-to)590-597
Number of pages8
ISSN0190-9622
DOIs
Publication statusPublished - 2022

Bibliographical note

Publisher Copyright:
© 2021 American Academy of Dermatology, Inc.

    Research areas

  • analgesics, itch, opioids, pain, patient-reported outcomes, psoriasis, psoriatic arthritis, quality of life

ID: 69204155